Back to EW
VANGUARD GROUP INC EW Position History
Edwards Lifesciences Corporation • Healthcare
Quarters held
24
Latest value
$276.5M
Q4 2025
Peak value
$5.5B
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $89.8M |
| Q1 2025 | $4.8B |
| Q1 2025 | $32K |
| Q1 2025 | $62.7M |
| Q1 2025 | $18.6M |
| Q1 2025 | $27M |
| Q2 2025 | $98.6M |
| Q2 2025 | $5.3B |
| Q2 2025 | $34K |
| Q2 2025 | $70.8M |
| Q2 2025 | $20.5M |
| Q2 2025 | $26.6M |
| Q3 2025 | $20.9M |
| Q3 2025 | $5B |
| Q3 2025 | $72.2M |
| Q3 2025 | $240.5M |
| Q3 2025 | $98.8M |
| Q3 2025 | $34K |
| Q4 2025 | $107.7M |
| Q4 2025 | $5.5B |
| Q4 2025 | $130K |
| Q4 2025 | $80.4M |
| Q4 2025 | $23.6M |
| Q4 2025 | $276.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $276.5M | 3.24M | — | — |
| Q4 2025 | $23.6M | 276.4K | — | — |
| Q4 2025 | $80.4M | 943.3K | — | — |
| Q4 2025 | $130K | 1.5K | — | — |
| Q4 2025 | $5.5B | 64.35M | — | — |
| Q4 2025 | $107.7M | 1.26M | — | — |
| Q3 2025 | $34K | 434 | — | — |
| Q3 2025 | $98.8M | 1.27M | — | — |
| Q3 2025 | $240.5M | 3.09M | — | — |
| Q3 2025 | $72.2M | 928.2K | — | — |
| Q3 2025 | $5B | 64.80M | — | — |
| Q3 2025 | $20.9M | 269.1K | — | — |
| Q2 2025 | $26.6M | 340.6K | — | — |
| Q2 2025 | $20.5M | 262.5K | — | — |
| Q2 2025 | $70.8M | 905.7K | — | — |
| Q2 2025 | $34K | 434 | — | — |
| Q2 2025 | $5.3B | 67.23M | — | — |
| Q2 2025 | $98.6M | 1.26M | — | — |
| Q1 2025 | $27M | 372.0K | — | — |
| Q1 2025 | $18.6M | 256.9K | — | — |
| Q1 2025 | $62.7M | 865.4K | — | — |
| Q1 2025 | $32K | 446 | — | — |
| Q1 2025 | $4.8B | 66.46M | — | — |
| Q1 2025 | $89.8M | 1.24M | — | — |
Other funds holding EW
$2.6B
$2.4B
$2.4B
$2.4B
$2.2B
$2.1B
$2.1B